Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study

被引:7
|
作者
Machado-Gedeon, Alexandre [1 ]
Badeghiesh, Ahmad [2 ]
Baghlaf, Haitham [3 ]
Dahan, Michael H. [4 ]
机构
[1] McGill Univ, Dept Obstet & Gynecol, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada
[2] Western Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, London, ON, Canada
[3] Univ Tabuk, Dept Obstet & Gynecol, Tabuk, Saudi Arabia
[4] McGill Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Montreal, PQ, Canada
关键词
Advanced maternal age; Assisted reproductive technology; Maternal outcomes; Neonatal outcomes; Pregnancy; Pregnancy outcomes; RISK;
D O I
10.1016/j.eurox.2023.100180
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Characterize the risk for adverse pregnancy, delivery and neonatal outcomes among different advanced maternal ages (AMA).Study design: We conducted a population-based retrospective cohort study using data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample to characterize adverse pregnancy, delivery and neonatal outcomes among different AMA groups. Patients aged 44-45 (n = 19,476), 46-49 (n = 7528) and 50-54 years (n = 1100) were compared to patients aged 38-43 years (n = 499,655). A multivariate logistic regression analysis adjusted for statistically significant confounding variables.Results: With advancing age, rates of chronic hypertension, pregestational diabetes, thyroid disease and multiple gestation increased (p < 0.001). The adjusted risk of hysterectomy and need for blood transfusion substantially increased with advancing age, reaching up to an almost 5-fold (aOR, 4.75, 95 % CI, 2.76-8.19, p < 0.001) and 3fold (aOR, 3.06, 95 % CI, 2.31-4.05, p < 0.001) increased risk, respectively, in patients aged 50-54 years. The adjusted risk of maternal death increased 4-fold in patients aged 46-49 years (aOR, 4.03, 95 % CI, 1.23-13.17, p = 0.021). Adjusted risks of pregnancy-related hypertensive disorders, including gestational hypertension and preeclampsia, increased by 28-93 % across advancing age groups (p < 0.001). Adjusted neonatal outcomes demonstrated up to a 40 % elevated risk of intrauterine fetal demise in patients aged 46-49 years (aOR, 1.40, 95 % CI, 1.02-1.92, p = 0.04) and a 17 % increased risk of having a small for gestational age neonate in patients aged 44-45 years (aOR, 1.17, 95 % CI, 1.05-1.31, p = 0.004).Conclusions: Pregnancies at AMA are at increased risk for adverse outcomes, particularly for pregnancy-related hypertensive disorders, hysterectomy, blood transfusion, and maternal and fetal mortality. Although comorbidities associated with AMA influence the risk of complications, AMA was demonstrated to be an independent risk factor for major complications, with its impact varying across ages. This data imparts clinicians with the ability to provide more specific counseling to patients of varied AMA. Older patients seeking to conceive must be counseled regarding these risks in order to make well-informed decisions.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Maternal lithium use and the risk of adverse pregnancy and neonatal outcomes: a Swedish population-based cohort study
    Hastie, Roxanne
    Tong, Stephen
    Hiscock, Richard
    Lindquist, Anthea
    Lindstroem, Linda
    Wikstroem, Anna-Karin
    Sundstroem-Poromaa, Inger
    [J]. BMC MEDICINE, 2021, 19 (01)
  • [2] Maternal lithium use and the risk of adverse pregnancy and neonatal outcomes: a Swedish population-based cohort study
    Roxanne Hastie
    Stephen Tong
    Richard Hiscock
    Anthea Lindquist
    Linda Lindström
    Anna-Karin Wikström
    Inger Sundström-Poromaa
    [J]. BMC Medicine, 19
  • [3] Association between maternal pregestational glucose level and adverse pregnancy outcomes: a population-based retrospective cohort study
    Zeng, Mengyao
    He, Yang
    Li, Min
    Yang, Liu
    Zhu, Qianxi
    Liu, Jun
    Mao, Yanyan
    Chen, Qing
    Du, Jing
    Zhou, Weijin
    [J]. BMJ OPEN, 2021, 11 (09):
  • [4] Hypertension subtypes and adverse maternal and perinatal outcomes - a retrospective population-based cohort study
    Perejon, Daniel
    Bardalet, Anna
    Gasco, Inaki
    Siscart, Julia
    Serna, Maria Catalina
    Oros, Miriam
    [J]. BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [5] Advanced Maternal Age and Risks for Adverse Pregnancy Outcomes: A Population-Based Study in Oman
    Islam, M. Mazharul
    Bakheit, Charles Saki
    [J]. HEALTH CARE FOR WOMEN INTERNATIONAL, 2015, 36 (10) : 1081 - 1103
  • [6] Maternal hyperthyroidism and pregnancy outcomes: A population-based cohort study
    Turunen, Suvi
    Vaarasmaki, Marja
    Lahesmaa-Korpinen, Anna-Maria
    Leinonen, Maarit K.
    Gissler, Mika
    Mannisto, Tuija
    Suvanto, Eila
    [J]. CLINICAL ENDOCRINOLOGY, 2020, 93 (06) : 721 - 728
  • [7] Antiseizure Medication Use in Pregnancy and Adverse Neonatal Birth Outcomes: A Population-Based Cohort Study
    Lavu, A.
    Peymani, P.
    Alessi-Severini, S.
    Ruth, C.
    Falk, J.
    Haidar, L.
    Aboulatta, L.
    Akinola, S.
    Farooq, F.
    Kowalec, K.
    Leong, C.
    Derksen, S.
    Ng, M.
    Delaney, J.
    Kaul, P.
    Eltonsy, S.
    [J]. BIRTH DEFECTS RESEARCH, 2023, 115 (08): : 882 - 882
  • [8] Gabapentin Use during Pregnancy and Adverse Neonatal Birth Outcomes: A Population-Based Cohort Study
    Lavu, A.
    Peymani, P.
    Severini, S. Alessi
    Ruth, C.
    Falk, J.
    Aboulatta, L.
    Haidar, L.
    Akinola, P. S.
    Farooq, F.
    Kowalec, K.
    Derksen, S.
    Leong, C.
    NG, M.
    Kaul, P.
    Delaney, J.
    Eltonsy, S.
    [J]. BIRTH DEFECTS RESEARCH, 2023, 115 (08): : 873 - 873
  • [9] Gabapentin use during pregnancy and adverse neonatal birth outcomes: A population-based cohort study
    Lavu, Alekhya
    Peymani, Payam
    Alessi-Severini, Silvia
    Ruth, Chelsea
    Falk, Jamison
    Kowalec, Kaarina
    Leong, Christine
    Haidar, Lara
    Aboulatta, Laila
    Akinola, Pelumi Samuel
    Farooq, Faiza
    Derksen, Shelley
    Ng, Marcus C.
    Kaul, Padma
    Delaney, Joseph
    Eltonsy, Sherif
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 520 - 521
  • [10] Gabapentin use during pregnancy and adverse neonatal birth outcomes: a population-based cohort study
    Lavu, A.
    Peymani, P.
    Alessi-Severini, S.
    Ruth, C.
    Falk, J.
    Kowalec, K.
    Leong, C.
    Derksen, S.
    Ng, M. C.
    Delaney, J.
    Eltonsy, S.
    [J]. EPILEPSIA, 2023, 64 : 21 - 21